Oxysterols Receiver LXR as A Potential Drug Target (P6482)

Target Name: Oxysterols receptor LXR

NCBI ID: P6482

Oxysterols receptor LXR

Other Name(s): Nuclear receptor NER | LXR

Oxysterols Receiver LXR as A Potential Drug Target

Oxysterols receptor LXR (nonspecified subtype) (Nuclear receptor NER), also known as XRML1, is a gene that encodes a nuclear receptor that is expressed in various tissues throughout the body. The oxysterols receptor is a key regulator of lipid metabolism and has been implicated in the development and progression of various diseases, including obesity, type 2 diabetes, and cardiovascular disease.

The oxysterols receptor is a member of the superfamily of nuclear receptors, which are a group of transcription factors that play a crucial role in regulating gene expression. These receptors are characterized by a nucleotide-binding oligomerization (NBO) domain, which is responsible for binding to DNA and activating gene transcription.

The oxysterols receptor is a non-coding RNA molecule that is expressed in various tissues, including muscle, heart, liver, and brain. It is highly expressed in adipose tissue, which is a major storage site for fat in the body. The receptor is also expressed in other tissues, including the liver, which is a major organ for glucose metabolism and lipid storage.

The oxysterols receptor is involved in the regulation of various cellular processes, including cell growth, differentiation, and metabolism. It has been shown to play a role in the development and progression of various diseases, including obesity, type 2 diabetes, and cardiovascular disease.

One of the key functions of the oxysterols receptor is its role in the regulation of lipid metabolism. The receptor is involved in the production and uptake of fatty acids into the mitochondria, where they can be used for energy production. In addition, the oxysterols receptor is involved in the regulation of lipid storage and metabolism in the liver.

The oxysterols receptor is also involved in the regulation of cellular signaling pathways. It has been shown to play a role in the regulation of several signaling pathways, including the TGF-β pathway and the Wnt pathway. These pathways are involved in cell growth, differentiation, and metabolism, and are important for the development and maintenance of tissues and organs.

In addition to its role in lipid metabolism and cellular signaling pathways, the oxysterols receptor is also involved in the regulation of cellular stress responses. It has been shown to play a role in the regulation of cellular stress responses, including the response to ionizing radiation and chemotherapy.

The oxysterols receptor is a potential drug target and biomarker for a variety of diseases. Its involvement in the regulation of lipid metabolism and cellular signaling pathways makes it a promising target for the development of interventions aimed at improving lipid profiles and reducing the risk of certain diseases.

In conclusion, the oxysterols receptor is a non-coding RNA molecule that is involved in the regulation of various cellular processes, including lipid metabolism and cellular signaling pathways. Its potential as a drug target and biomarker makes it an attractive target for the development of interventions aimed at improving health and reducing the risk of certain diseases. Further research is needed to fully understand the role of the oxysterols receptor in the regulation of cellular processes and its potential as a drug target.

Protein Name: Oxysterols Receptor LXR (nonspecified Subtype)

The "Oxysterols receptor LXR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Oxysterols receptor LXR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets